Author

Nikolaos Charalampakis

Observed names: Charalampakis, N., Charalampakis, Nikolaos, N. Charalambakis, N. Charalampakis, Nick Charalampakis, Nikolaos Charalambakis

Institution: Metaxa Hospital

Observed institutions: The University of Texas MD Anderson Cancer Center, National and Kapodistrian University of Athens, Juntendo University, National Cancer Centre Japan, Hellenic Cooperative Oncology Group, Metaxa Hospital, University General Hospital Attikon, Henry Dunant Hospital, National Cancer Center Hospital

ORCID: 0000-0002-8756-9659

Observed ORCID: 0000-0002-8756-9659

OpenAlex ID: A5087337299

Immunotherapy for pancreatic cancer: A 2020 update

2020 · Dimitrios Schizas, Nikolaos Charalampakis, et al. · Cancer Treatment Reviews · 467

Medical management of gastric cancer: a 2017 update

2017 · Nikolaos Charalampakis, Panagiota Economopoulou, et al. · Cancer Medicine · 181

PDF

Oncology during the COVID‑19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients (Review)

2020 · Konstantinos Tsamakis, Maria Gavriatopoulou, et al. · Oncology Letters · 169

PDF

Immunotherapy for Hepatocellular Carcinoma: A 2021 Update

2020 · Christo Kole, Nikolaos Charalampakis, et al. · Cancers · 144

The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation

2016 · Nikolaos Charalampakis, Graciela M. Nogueras González, et al. · Oncology · 60

18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients

2015 · Elena Elimova, Xuemei Wang, et al. · European Journal of Cancer · 59

Immunotherapy for Gastric Cancer: A 2021 Update

2021 · Christo Kole, Nikolaos Charalampakis, et al. · Immunotherapy · 46

The role of surgical treatment in isolated organ recurrence of esophageal cancer—a systematic review of the literature

2018 · Dimitrios Schizas, Ioannis I. Lazaridis, et al. · World Journal of Surgical Oncology · 46

PDF

Immunotherapy for Esophageal Cancer: A 2019 Update

2020 · Dimitrios Schizas, Nikolaos Charalampakis, et al. · Immunotherapy · 38

Current and Potential Biomarkers in Gastric Cancer: a Critical Review of the Literature

2021 · Ramon Andrade de Mello, Giovanna Araujo Amaral, et al. · Future Oncology · 32

Prognostic Significance of Serum Inflammatory Response Markers in Newly Diagnosed Non-Small Cell Lung Cancer before Chemoirradiation

2015 · Maria Tolia, Nikolaos Tsoukalas, et al. · BioMed Research International · 21

PDF

Immunotherapy for Cholangiocarcinoma: a 2021 Update

2021 · Nikolaos Charalampakis, Georgios Papageorgiou, et al. · Immunotherapy · 19

Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights

2022 · Christo Kole, Nikolaos Charalampakis, et al. · Cancer Management and Research · 18

PDF

A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer

2016 · Kazuki Sudo, Xuemei Wang, et al. · Journal of the National Comprehensive Cancer Network · 18

PDF

Hereditary Diffuse Gastric Cancer: A 2022 Update

2022 · Christo Kole, Nikolaos Charalampakis, et al. · Journal of Personalized Medicine · 17

PDF

Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance

2017 · Elena Elimova, Rebecca S. Slack, et al. · Oncotarget · 16

PDF

Immunotherapy for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a 2021 update

2021 · Christo Kole, Nikolaos Charalampakis, et al. · Cancer Immunology Immunotherapy · 13

Impact of radiation therapy on pain relief of cancer patients affected by on malignant psoas syndrome: 26 years of experience

2020 · Alexandros Gerontopoulos, Eftychia Mosa, et al. · Indian Journal of Palliative Care · 12

Immune Checkpoint Inhibitors and Combinations with Other Agents in Cholangiocarcinoma

2023 · Nikolaos Skouteris, Georgios Papageorgiou, et al. · Immunotherapy · 11

Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors

2016 · Hironori Shiozaki, Rebecca S. Slack, et al. · Oncology · 11

Current Cardioprotective Strategies for the Prevention of Radiation-Induced Cardiotoxicity in Left-Sided Breast Cancer Patients

2023 · Vasiliki Nikovia, Evangelos Chinis, et al. · Journal of Personalized Medicine · 10

PDF

Radiation-Induced Esophageal Cancer: Investigating the Pathogenesis, Management, and Prognosis

2022 · Athanasios Syllaios, Michail Vailas, et al. · Medicina · 10

PDF

Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives

2022 · Nikolaos Charalampakis, Sergios Tsakatikas, et al. · World Journal of Gastrointestinal Oncology · 10

Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Cholangiocarcinoma

2020 · Aikaterini Mastoraki, Dimitrios Schizas, et al. · Molecular Diagnosis & Therapy · 10

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma

2016 · Nikolaos Charalampakis, Lianchun Xiao, et al. · Annals of Surgical Oncology · 10

Works count: 78

Citation count: 1,596

H-index: 16

I10-index: 25